| Year |
Citation |
Score |
| 2020 |
Mittempergher L, Piskorz AM, Bosma AJ, Michaut M, Wisman GBA, Kluin RJC, Nieuwland M, Brugman W, van der Ven KJW, Marass F, Morris J, Rosenfeld N, Jimenez-Linan M, de Jong S, van der Zee AGJ, et al. Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene. Plos One. 15: e0235766. PMID 32639993 DOI: 10.1371/Journal.Pone.0235766 |
0.344 |
|
| 2020 |
Wan JCM, Heider K, Gale D, Murphy S, Fisher E, Mouliere F, Ruiz-Valdepenas A, Santonja A, Morris J, Chandrananda D, Marshall A, Gill AB, Chan PY, Barker E, Young G, ... ... Rosenfeld N, et al. ctDNA monitoring using patient-specific sequencing and integration of variant reads. Science Translational Medicine. 12. PMID 32554709 DOI: 10.1126/Scitranslmed.Aaz8084 |
0.407 |
|
| 2020 |
Nygård L, Ahlborn LB, Persson GF, Chandrananda D, Langer JW, Fischer BM, Langer SW, Gabrielaite M, Kjær A, Rosenfeld N, Mouliere F, Østrup O, Vogelius IR, Bentzen SM. Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations. Plos One. 15: e0231884. PMID 32343749 DOI: 10.1371/Journal.Pone.0231884 |
0.413 |
|
| 2020 |
Heider K, Wan JCM, Hall J, Belic J, Boyle S, Hudecova I, Gale D, Cooper WN, Corrie PG, Brenton JD, Smith CG, Rosenfeld N. Detection of ctDNA from Dried Blood Spots after DNA Size Selection. Clinical Chemistry. PMID 32268361 DOI: 10.1093/Clinchem/Hvaa050 |
0.343 |
|
| 2020 |
Smith CG, Moser T, Mouliere F, Field-Rayner J, Eldridge M, Riediger AL, Chandrananda D, Heider K, Wan JCM, Warren AY, Morris J, Hudecova I, Cooper WN, Mitchell TJ, Gale D, ... ... Rosenfeld N, et al. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors. Genome Medicine. 12: 23. PMID 32111235 DOI: 10.1186/S13073-020-00723-8 |
0.388 |
|
| 2020 |
Heider K, Gale DG, Marsico G, Ruiz-Valdepeñas A, Sharma G, Perry M, Osborne R, Howarth K, Rundell V, Belic J, Wulff J, Harden S, Rassl DM, Rintoul R, Rosenfeld N. Detection of residual disease and recurrence in early-stage non-small cell lung cancer (NSCLC) patients using sensitive personalized ctDNA sequencing assays. Journal of Clinical Oncology. 38: e15560-e15560. DOI: 10.1200/Jco.2020.38.15_Suppl.E15560 |
0.362 |
|
| 2020 |
Heider K, Wan JC, Gale D, Ruiz-Valdepenas A, Mouliere F, Morris J, Qureshi NR, Qian W, Wulff J, Demiris N, Howarth K, Green E, Rundell V, Eisen T, Cooper W, ... ... Rosenfeld N, et al. Abstract 736: ctDNA detection in early stage non-small cell lung cancer Clinical Trials. 80: 736-736. DOI: 10.1158/1538-7445.Am2020-736 |
0.397 |
|
| 2020 |
Heider K, Gale D, Ruiz-Valdepenas A, Marsico G, Sharma G, Perry M, Osborne R, Howarth K, Lazarus T, Rundell V, Belic J, Wulff J, Harden S, Rassl DM, Rintoul RC, ... Rosenfeld N, et al. Abstract 735: Sensitive detection of ctDNA in early stage non-small cell lung cancer patients with a personalized sequencing assay Clinical Trials. DOI: 10.1158/1538-7445.Am2020-735 |
0.342 |
|
| 2019 |
Heider K, Wan JC, Gale D, Mouliere FC, Qian W, Kateb A, Doughton G, Ramenatte N, Tysoe R, Smith CG, Rassl DM, Harden S, Rintoul RC, Massie C, Rosenfeld N. Abstract 1377: Improved ctDNA detection in early stage non-small-cell lung cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1377 |
0.315 |
|
| 2019 |
Smith CG, Wan JC, Heider K, Mouliere FC, Mair R, Eldridge M, Brindle K, Corrie PG, Stewart GD, Rosenfeld N. Abstract 447: Sensitive detection of ctDNA in low burden and ‘challenging’ cancers Cancer Research. 79: 447-447. DOI: 10.1158/1538-7445.Am2019-447 |
0.361 |
|
| 2019 |
Moser T, Smith CG, Seles M, Wcislo G, Eldridge M, Perakis S, Mouliere F, Lazzeri I, Heider K, Warren A, Rosenfeld N, Stewart GD, Heitzer E. Abstract 1367: Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors Cancer Research. 79: 1367-1367. DOI: 10.1158/1538-7445.Am2019-1367 |
0.375 |
|
| 2019 |
Nygaard L, Ahlborn L, Persson G, Chandrananda D, Langer J, Fischer B, Aznar M, Langer S, Gabrielaite M, Kjær A, Rosenfeld N, Mouliere F, Østrup O, Vogelius I, Bentzen S. EP-1368 Circulating cell free DNA during chemoradiotherapy in non-small cell lung cancer patients Radiotherapy and Oncology. 133: S747-S748. DOI: 10.1016/S0167-8140(19)31788-8 |
0.382 |
|
| 2018 |
Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, ... ... Rosenfeld N, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Science Translational Medicine. 10. PMID 30404863 DOI: 10.1126/Scitranslmed.Aat4921 |
0.382 |
|
| 2018 |
Mouliere F, Mair R, Chandrananda D, Marass F, Smith CG, Su J, Morris J, Watts C, Brindle KM, Rosenfeld N. Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. Embo Molecular Medicine. PMID 30401727 DOI: 10.15252/Emmm.201809323 |
0.391 |
|
| 2018 |
Mair R, Mouliere F, Smith CG, Chandrananda D, Gale D, Marass F, Tsui DWY, Massie CE, Wright AJ, Watts C, Rosenfeld N, Brindle KM. Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models. Cancer Research. PMID 30389699 DOI: 10.1158/0008-5472.Can-18-0074 |
0.411 |
|
| 2018 |
Risberg B, Tsui DW, Biggs H, Ruiz-Valdepenas Martin de Almagro A, Dawson SJ, Hodgkin C, Jones L, Parkinson C, Piskorz A, Marass F, Chandrananda D, Moore E, Morris J, Plagnol V, Rosenfeld N, et al. Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients. The Journal of Molecular Diagnostics : Jmd. PMID 30165204 DOI: 10.1016/J.Jmoldx.2018.07.005 |
0.372 |
|
| 2018 |
Tsui DWY, Murtaza M, Wong ASC, Rueda OM, Smith CG, Chandrananda D, Soo RA, Lim HL, Goh BC, Caldas C, Forshew T, Gale D, Liu W, Morris J, Marass F, ... ... Rosenfeld N, et al. Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer. Embo Molecular Medicine. PMID 29848757 DOI: 10.15252/Emmm.201707945 |
0.4 |
|
| 2018 |
Gale D, Lawson ARJ, Howarth K, Madi M, Durham B, Smalley S, Calaway J, Blais S, Jones G, Clark J, Dimitrov P, Pugh M, Woodhouse S, Epstein M, Fernandez-Gonzalez A, ... ... Rosenfeld N, et al. Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA. Plos One. 13: e0194630. PMID 29547634 DOI: 10.1371/Journal.Pone.0194630 |
0.402 |
|
| 2018 |
Plagnol V, Woodhouse S, Howarth K, Lensing S, Smith M, Epstein M, Madi M, Smalley S, Leroy C, Hinton J, de Kievit F, Musgrave-Brown E, Herd C, Baker-Neblett K, Brennan W, ... ... Rosenfeld N, et al. Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling. Plos One. 13: e0193802. PMID 29543828 DOI: 10.1371/Journal.Pone.0193802 |
0.422 |
|
| 2018 |
Goldman JW, Noor ZS, Remon J, Besse B, Rosenfeld N. Are liquid biopsies a surrogate for tissue EGFR testing? Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: i38-i46. PMID 29462257 DOI: 10.1093/Annonc/Mdx706 |
0.342 |
|
| 2018 |
Woodhouse S, Plagnol V, Howarth K, Lensing S, Smith M, Epstein M, Madi M, Smalley S, Leroy C, Hinton J, Kievit Fd, Musgrave-Brown E, Herd C, Baker-Neblett K, Brennan W, ... ... Rosenfeld N, et al. Abstract 939: Analytical validation of InVisionFirst™, a liquid biopsy assay for high-sensitivity broad molecular profiling of circulating tumor DNA using plasma samples of cancer patients Cancer Research. 78: 939-939. DOI: 10.1158/1538-7445.Am2018-939 |
0.427 |
|
| 2018 |
Patel K, Massie C, Marass F, Morris J, Lynch A, Mouliere F, Neal D, Gnanapragasam V, Forshew T, Rosenfeld N. PD56-03 DETECTION OF PRIVATE CLONAL MUTATIONS IN LOCALISED PROSTATE CANCER FROM RARE MOLECULES OF CIRCULATING TUMOUR DNA Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2635 |
0.311 |
|
| 2018 |
Remon J, Jovelet C, Lacroix L, Planchard D, Mezquita L, Howarth K, Green E, Plagnol V, Morris C, Rosenfeld N, Caramella C, Lepéchoux C, Aboubakar Nana F, Botticella A, Adam J, et al. P2.13-24 Prospective Efficacy of Osimertinib in Circulating Tumour DNA (ctDNA) T790M-Mutant NSCLC Patients Journal of Thoracic Oncology. 13: S807-S808. DOI: 10.1016/J.Jtho.2018.08.1419 |
0.335 |
|
| 2017 |
Fribbens C, Garcia Murillas I, Beaney M, Hrebien S, O'Leary B, Kilburn L, Howarth K, Epstein M, Green E, Rosenfeld N, Ring A, Johnston S, Turner N. Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29045530 DOI: 10.1093/Annonc/Mdx483 |
0.309 |
|
| 2017 |
Patel KM, van der Vos KE, Smith CG, Mouliere F, Tsui D, Morris J, Chandrananda D, Marass F, van den Broek D, Neal DE, Gnanapragasam VJ, Forshew T, van Rhijn BW, Massie CE, Rosenfeld N, et al. Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer. Scientific Reports. 7: 5554. PMID 28717136 DOI: 10.1038/S41598-017-05623-3 |
0.376 |
|
| 2017 |
Wan JC, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews. Cancer. PMID 28233803 DOI: 10.1038/Nrc.2017.7 |
0.357 |
|
| 2017 |
Remon J, Caramella C, Jovelet C, Lacroix L, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Planchard D, Bluthgen MV, Gazzah A, Pannet C, et al. Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28104619 DOI: 10.1093/Annonc/Mdx017 |
0.345 |
|
| 2017 |
Wan J, Murphy S, Gale DG, Morris JA, Mouliere F, Gill A, Marass F, Heider K, Parkinson C, Gallagher FA, Durrani AJ, McDermott U, Massie C, Corrie P, Rosenfeld N. A pilot study of individualised monitoring of patients with metastatic melanoma using plasma and urine DNA. Journal of Clinical Oncology. 35: e21032-e21032. DOI: 10.1200/Jco.2017.35.15_Suppl.E21032 |
0.393 |
|
| 2017 |
Fribbens CV, Garcia-Murillas I, Beaney M, Hrebien S, Howarth K, Epstein M, Rosenfeld N, Ring AE, Johnston SRD, Turner NC. Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA (ctDNA) in metastatic breast cancer. Journal of Clinical Oncology. 35: 1015-1015. DOI: 10.1200/Jco.2017.35.15_Suppl.1015 |
0.354 |
|
| 2017 |
Piskorz A, Lin KK, Morris J, Mann E, Oza A, Coleman RL, O'Malley DM, Friedlander M, Cragun JM, Ma L, Giordano H, Rosenfeld N, Raponi M, McNeish IA, Swisher E, et al. Abstract AP27: FEASIBILITY OF MONITORING RESPONSE TO THE PARP INHIBITOR RUCAPARIB WITH TARGETED DEEP SEQUENCING OF CIRCULATING TUMOR DNA (CTDNA) IN WOMEN WITH HIGH GRADE OVARIAN CARCINOMA ON THE ARIEL2 TRIAL Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Ap27 |
0.403 |
|
| 2017 |
Garcia-Murillas I, Beanney M, Epstein M, Howarth K, Lawson A, Hrebien S, Green E, Rosenfeld N, Turner N. Abstract 2743: Comparison of enhanced Tagged-Amplicon Sequencing and digital PCR for circulating tumor DNA analysis in advanced breast cancer Cancer Research. 77: 2743-2743. DOI: 10.1158/1538-7445.Am2017-2743 |
0.384 |
|
| 2017 |
Wan J, Murphy S, Gale D, Morris J, Mouliere FC, Marass F, Heider K, Chandrananda D, Bignell G, Parkinson C, Durrani A, McDermott U, Massie C, Corrie P, Rosenfeld N. Individualised monitoring of patients with metastatic melanoma using plasma DNA The Lancet. 389: S99. DOI: 10.1016/S0140-6736(17)30495-6 |
0.394 |
|
| 2017 |
Ruiz-Valdepenas A, Heider K, Doughton G, Qian W, Massie C, Chandrananda D, Smith C, Gale D, Moseley E, Castedo C, Stone A, Thorbinson C, Eisen T, Rassl D, Harden S, ... ... Rosenfeld N, et al. MA 11.02 Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update Journal of Thoracic Oncology. 12: S1843-S1844. DOI: 10.1016/J.Jtho.2017.09.543 |
0.326 |
|
| 2016 |
Parkinson CA, Gale D, Piskorz AM, Biggs H, Hodgkin C, Addley H, Freeman S, Moyle P, Sala E, Sayal K, Hosking K, Gounaris I, Jimenez-Linan M, Earl HM, Qian W, ... Rosenfeld N, et al. Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study. Plos Medicine. 13: e1002198. PMID 27997533 DOI: 10.1371/Journal.Pmed.1002198 |
0.37 |
|
| 2016 |
Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, ... ... Rosenfeld N, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nature Communications. 7: 11479. PMID 27161491 DOI: 10.1038/Ncomms11479 |
0.341 |
|
| 2016 |
Swanton C, Soria JC, Bardelli A, Biankin A, Caldas C, Chandarlapaty S, de Koning L, Dive C, Feunteun J, Leung SY, Marais R, Mardis ER, McGranahan N, Middleton G, Quezada SA, ... ... Rosenfeld N, et al. Consensus on precision medicine for metastatic cancers: A report from the MAP conference. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 27143638 DOI: 10.1093/Annonc/Mdw192 |
0.332 |
|
| 2016 |
Marass F, Mouliere F, Yuan K, Rosenfeld N, Markowetz F. A phylogenetic latent feature model for clonal deconvolution The Annals of Applied Statistics. 10: 2377-2404. DOI: 10.1214/16-Aoas986 |
0.307 |
|
| 2016 |
Parkinson CA, Gale D, Piskorz A, Hodgkin C, Biggs H, Addley H, Moyle P, Freeman S, Sala E, Hosking K, Gounaris I, Jimenez-Linan M, Earl HM, Qian W, Rosenfeld N, et al. Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer. Journal of Clinical Oncology. 34: e23040-e23040. DOI: 10.1200/Jco.2016.34.15_Suppl.E23040 |
0.356 |
|
| 2016 |
Remon J, Soria J, Lacroix L, Howarth K, Lawson A, Smalley S, Gale D, Plagnol V, Green E, Rosenfeld N, Jovelet C, Pannet C, Besse B. Evaluation of liquid biopsies for molecular profiling and monitoring in non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology. 34: 11533-11533. DOI: 10.1200/Jco.2016.34.15_Suppl.11533 |
0.319 |
|
| 2016 |
Garcia-Corbacho J, Mouliere F, Carr H, Morris JA, Marrass F, Gale DG, Kumar S, Hategan M, Zabrautanu M, Dott W, Harrington EA, Dougherty BA, Barrett JC, Basu B, Brenton JD, ... ... Rosenfeld N, et al. CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number changes. Journal of Clinical Oncology. 34: 11530-11530. DOI: 10.1200/Jco.2016.34.15_Suppl.11530 |
0.348 |
|
| 2016 |
Gale D, Plagnol V, Lawson A, Pugh M, Smalley S, Howarth K, Madi M, Durham B, Kumanduri V, Lo K, Clark J, Green E, Rosenfeld N, Forshew T. Abstract 3639: Analytical performance and validation of an enhanced TAm-Seq circulating tumor DNA sequencing assay Cancer Research. 76: 3639-3639. DOI: 10.1158/1538-7445.Am2016-3639 |
0.42 |
|
| 2016 |
Remon J, Soria JC, Planchard D, Jovelet C, Pannet C, Lacroix L, Gazzah A, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Oulassen K, et al. Abstract 3192: Liquid biopsies for molecular profiling of mutations in non-small cell lung cancer patients lacking tissue samples Cancer Research. 76: 3192-3192. DOI: 10.1158/1538-7445.Am2016-3192 |
0.391 |
|
| 2015 |
Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, Farahani H, Shumansky K, ... ... Rosenfeld N, et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nature Communications. 6: 8760. PMID 26530965 DOI: 10.1038/Ncomms9760 |
0.38 |
|
| 2015 |
Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, ... ... Rosenfeld N, et al. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nature Communications. 6: 6605. PMID 25827447 DOI: 10.1038/Ncomms7605 |
0.328 |
|
| 2015 |
Mouliere F, Rosenfeld N. Circulating tumor-derived DNA is shorter than somatic DNA in plasma. Proceedings of the National Academy of Sciences of the United States of America. 112: 3178-9. PMID 25733911 DOI: 10.1073/Pnas.1501321112 |
0.332 |
|
| 2015 |
Plagnol V, Lawson A, Forshew T, Fahem A, Brenton J, Gale D, Rosenfeld N. Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform. Journal of Clinical Oncology. 33: e22057-e22057. DOI: 10.1200/Jco.2015.33.15_Suppl.E22057 |
0.41 |
|
| 2015 |
Lawson AR, Plagnol V, Fahem A, Forshew T, Brenton JD, Gale D, Rosenfeld N. Abstract 2412: Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform Cancer Research. 75: 2412-2412. DOI: 10.1158/1538-7445.Am2015-2412 |
0.316 |
|
| 2015 |
Smalley SK, Gale D, Lawson AR, Remon-Masip J, Perez E, Pugh M, Howarth K, Touat M, Soria J, Hollebecque A, Besse B, Forshew T, Plagnol V, Lacroix L, Rosenfeld N. Abstract B7: Assessing the clinical applications of ctDNA in patients with advanced stage metastatic cancer using our enhanced TAm-Seq platform Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B7 |
0.404 |
|
| 2014 |
Weaver JM, Ross-Innes CS, Shannon N, Lynch AG, Forshew T, Barbera M, Murtaza M, Ong CA, Lao-Sirieix P, Dunning MJ, Smith L, Smith ML, Anderson CL, Carvalho B, O'Donovan M, ... ... Rosenfeld N, et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nature Genetics. 46: 837-43. PMID 24952744 DOI: 10.1038/Ng.3013 |
0.333 |
|
| 2014 |
Gossage L, Murtaza M, Slatter AF, Lichtenstein CP, Warren A, Haynes B, Marass F, Roberts I, Shanahan SJ, Claas A, Dunham A, May AP, Rosenfeld N, Forshew T, Eisen T. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. Genes, Chromosomes & Cancer. 53: 38-51. PMID 24166983 DOI: 10.1002/Gcc.22116 |
0.36 |
|
| 2014 |
Tsui D, Wong A, Murtaza M, Forshew T, Soo R, Lim H, Goh B, Gale D, Chin T, Rosenfeld N. 58: Proffered Paper: Noninvasive monitoring of tumour mutations and dynamics in circulating DNA of non-small cell lung cancer patients treated with EGFR inhibitors European Journal of Cancer. 50: S14-S15. DOI: 10.1016/S0959-8049(14)50058-5 |
0.388 |
|
| 2014 |
Weaver JM, Ross-Innes C, Shannon NB, Lynch A, Forshew T, Barbera M, Ong CJ, Murtaza M, Lao-Sirieix P, Dunning MJ, Smith L, Smith M, Carvalho B, Underwood T, May A, ... ... Rosenfeld N, et al. 935 The Timing of Oncogenic Events in the Evolution of the Oesophageal Adenocarcinoma Genome and Implications for Clinical Diagnostics Gastroenterology. 146: S-161. DOI: 10.1016/S0016-5085(14)60576-X |
0.347 |
|
| 2013 |
Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, ... ... Rosenfeld N, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature Genetics. 45: 1055-60. PMID 23913004 DOI: 10.1038/Ng.2716 |
0.303 |
|
| 2013 |
Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, Bentley D, Chin TM, ... ... Rosenfeld N, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 497: 108-12. PMID 23563269 DOI: 10.1038/Nature12065 |
0.386 |
|
| 2013 |
Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, ... ... Rosenfeld N, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. The New England Journal of Medicine. 368: 1199-209. PMID 23484797 DOI: 10.1056/Nejmoa1213261 |
0.365 |
|
| 2013 |
Rosenfeld N. Abstract SY11-03: Circulating tumor DNA as a non-invasive diagnostic and research tool. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Sy11-03 |
0.432 |
|
| 2012 |
Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, Dawson SJ, Piskorz AM, Jimenez-Linan M, Bentley D, Hadfield J, May AP, Caldas C, Brenton JD, Rosenfeld N. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Science Translational Medicine. 4: 136ra68. PMID 22649089 DOI: 10.1126/Scitranslmed.3003726 |
0.429 |
|
| 2012 |
Young JW, Locke JC, Altinok A, Rosenfeld N, Bacarian T, Swain PS, Mjolsness E, Elowitz MB. Measuring single-cell gene expression dynamics in bacteria using fluorescence time-lapse microscopy. Nature Protocols. 7: 80-8. PMID 22179594 DOI: 10.1038/Nprot.2011.432 |
0.325 |
|
| 2012 |
Dawson S, Tsui D, Murtaza M, Biggs H, Chin S, Gale D, Forshew T, Wallis M, Caldas C, Rosenfeld N. 876 Non-invasive Monitoring of Metastatic Breast Cancer by Circulating Tumour DNA – a Comparison With Circulating Tumour Cells European Journal of Cancer. 48: S211-S212. DOI: 10.1016/S0959-8049(12)71508-3 |
0.348 |
|
| 2012 |
Dawson S, Tsui D, Murtaza M, Biggs H, Chin S, Gale D, Forshew T, Wallis M, Rosenfeld N, Caldas C. Monitoring of Metastatic Breast Cancer Using Circulating Tumour DNA: A Comparison With Circulating Tumour Cells Annals of Oncology. 23: ix74. DOI: 10.1016/S0923-7534(20)32772-1 |
0.4 |
|
| 2010 |
Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, Ashkenazi K, Goren E, Meiri E, Morgenstern S, Perelman M, Barshack I, Goren Y, Edmonston TB, Chajut A, ... ... Rosenfeld N, et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. The Journal of Molecular Diagnostics : Jmd. 12: 771-9. PMID 20864637 DOI: 10.2353/Jmoldx.2010.090169 |
0.312 |
|
| 2010 |
Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, Avivi C, Rosenblatt K, Polak-Charcon S, Ramon J, Rosenfeld N, et al. Accurate molecular classification of renal tumors using microRNA expression. The Journal of Molecular Diagnostics : Jmd. 12: 687-96. PMID 20595629 DOI: 10.2353/Jmoldx.2010.090187 |
0.301 |
|
| 2010 |
Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, Barshack I, Nass D, Tobar A, Feinmesser M, Rosenfeld N, et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 23: 814-23. PMID 20348879 DOI: 10.1038/Modpathol.2010.57 |
0.305 |
|
| 2009 |
Rosenwald S, Gibori H, Gilad S, Cohen L, Leizerman I, Barshack I, Nonaka D, Tobar A, Aharonov R, Rosenfeld N. Identification of tumor tissue origin by a microRNA-based molecular assay. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11036. PMID 27964010 DOI: 10.1200/Jco.2009.27.15_Suppl.11036 |
0.333 |
|
| 2009 |
Lebanony D, Benjamin H, Gilad S, Ashkenazi K, Nonaka D, Feinmesser M, Rosenfeld N, Chajut A, Cohen D, Aharonov R. MicroRNA-based assay for differential diagnosis of squamous from non-squamous non-small cell lung carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 11069. PMID 27963144 DOI: 10.1200/Jco.2009.27.15_Suppl.11069 |
0.326 |
|
| 2009 |
Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2030-7. PMID 19273703 DOI: 10.1200/Jco.2008.19.4134 |
0.364 |
|
| 2007 |
Rosenfeld N, Young JW, Alon U, Swain PS, Elowitz MB. Accurate prediction of gene feedback circuit behavior from component properties. Molecular Systems Biology. 3: 143. PMID 18004276 DOI: 10.1038/Msb4100185 |
0.483 |
|
| 2006 |
Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Liron Y, Rosenfeld N, Danon T, Perzov N, Alon U. Variability and memory of protein levels in human cells. Nature. 444: 643-6. PMID 17122776 DOI: 10.1038/Nature05316 |
0.666 |
|
| 2006 |
Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, Liron Y, Polak P, Lahav G, Alon U. Oscillations and variability in the p53 system. Molecular Systems Biology. 2: 2006.0033. PMID 16773083 DOI: 10.1038/Msb4100068 |
0.723 |
|
| 2006 |
Rosenfeld N, Perkins TJ, Alon U, Elowitz MB, Swain PS. A fluctuation method to quantify in vivo fluorescence data. Biophysical Journal. 91: 759-66. PMID 16648159 DOI: 10.1529/Biophysj.105.073098 |
0.485 |
|
| 2005 |
Rosenfeld N, Young JW, Alon U, Swain PS, Elowitz MB. Gene regulation at the single-cell level. Science (New York, N.Y.). 307: 1962-5. PMID 15790856 DOI: 10.1126/Science.1106914 |
0.53 |
|
| 2004 |
Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB, Alon U. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nature Genetics. 36: 147-50. PMID 14730303 DOI: 10.1038/Ng1293 |
0.723 |
|
| 2003 |
Rosenfeld N, Alon U. Response delays and the structure of transcription networks. Journal of Molecular Biology. 329: 645-54. PMID 12787666 DOI: 10.1016/S0022-2836(03)00506-0 |
0.47 |
|
| 2002 |
Rosenfeld N, Elowitz MB, Alon U. Negative autoregulation speeds the response times of transcription networks. Journal of Molecular Biology. 323: 785-93. PMID 12417193 DOI: 10.1016/S0022-2836(02)00994-4 |
0.5 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Pereira B, Chin SF, Rueda OM, Vollan HM, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, ... ... Rosenfeld N, et al. Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nature Communications. 7: 11908. PMID 27264733 DOI: 10.1038/Ncomms11908 |
0.297 |
|
| 2019 |
Smith C, Heitzer E, Moser T, Mouliere F, Chandrananda D, Mitchell T, Warren A, Burge J, Armitage J, Riddick T, Aho T, Eldridge M, Massie C, Rosenfeld N, Stewart G. LBA-14 COMPREHENSIVE CHARACTERISATION OF CIRCULATING TUMOUR DNA IN PLASMA AND URINE OF PATIENTS WITH RENAL TUMOURS: RESULTS OF THE DIAMOND AND MONREC STUDIES Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557506.46205.F9 |
0.295 |
|
| 2016 |
Murphy S, Wan J, Gale D, Morris J, Mouliere F, Bignell G, Alifrangis C, Parkinson C, Durrani A, McDermott U, Massie C, Corrie P, Rosenfeld N. Monitoring metastatic melanoma treatment resistance using circulating tumour DNA European Journal of Cancer. 61: S196. DOI: 10.1016/S0959-8049(16)61694-5 |
0.292 |
|
| 2015 |
Schwarz RF, Ng CK, Cooke SL, Newman S, Temple J, Piskorz AM, Gale D, Sayal K, Murtaza M, Baldwin PJ, Rosenfeld N, Earl HM, Sala E, Jimenez-Linan M, Parkinson CA, et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. Plos Medicine. 12: e1001789. PMID 25710373 DOI: 10.1371/Journal.Pmed.1001789 |
0.29 |
|
| 2010 |
Barshack I, Meiri E, Rosenwald S, Lebanony D, Bronfeld M, Aviel-Ronen S, Rosenblatt K, Polak-Charcon S, Leizerman I, Ezagouri M, Zepeniuk M, Shabes N, Cohen L, Tabak S, Cohen D, ... ... Rosenfeld N, et al. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression. The International Journal of Biochemistry & Cell Biology. 42: 1355-62. PMID 20619223 DOI: 10.1016/J.Biocel.2009.02.021 |
0.29 |
|
| 2011 |
Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World Journal of Gastroenterology : Wjg. 17: 3976-85. PMID 22046085 DOI: 10.3748/Wjg.V17.I35.3976 |
0.284 |
|
| 2008 |
Rosenwald S, Meiri E, Gilad S, Ezagouri M, Spector Y, Ben Ari A, Levy A, Aharonov R, Rosenfeld N, Barshack I. MicroRNA signature identifies tissue origin of primary and metastatic tumors Journal of Clinical Oncology. 26: 11028-11028. DOI: 10.1200/Jco.2008.26.15_Suppl.11028 |
0.283 |
|
| 2018 |
Govindan R, Pritchett M, Camidge D, Patel M, Khatri J, Boniol S, Friedman E, Khomani A, Dalia S, Baker-Neblett K, Plagnol V, Howarth K, Rosenfeld N, Morris C. MA16.02 Prospective Clinical Validation of the InVisionFirst™ ctDNA Assay for Molecular Profiling of Patients with Advanced NSCLC Journal of Thoracic Oncology. 13: S411-S412. DOI: 10.1016/J.Jtho.2018.08.449 |
0.282 |
|
| 2008 |
Nass D, Rosenwald S, Sitbon E, Lithwick G, Elyakim E, Cholakh H, Spector Y, Rosenfeld N, Aharonov R, Barshack I, Bentwich Z. MicroRNAs as specific biomarkers for distinguishing between primary and metastatic brain tumors Journal of Clinical Oncology. 26: 13002-13002. DOI: 10.1200/Jco.2008.26.15_Suppl.13002 |
0.278 |
|
| 2019 |
Remon J, Lacroix L, Jovelet C, Caramella C, Howarth K, Plagnol V, Rosenfeld N, Morris C, Mezquita L, Pannet C, Ngocamus M, Le Pechoux C, Adam J, Grecea AM, Planchard D, et al. Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non-Small-Cell Lung Cancer. Jco Precision Oncology. 3. PMID 32914037 DOI: 10.1200/PO.18.00211 |
0.276 |
|
| 2017 |
Remon J, Caramella C, Joelet C, Lacroix L, Lawson A, Smalley S, Howarth K, Gale D, Rosenfeld N, Green E, Plagnol V, Planchard D, Bluthgen M, Gazzah A, Pannet C, et al. P3.02b-102 Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients Journal of Thoracic Oncology. 12: S1254-S1255. DOI: 10.1016/J.Jtho.2016.11.1770 |
0.273 |
|
| 2021 |
Mouliere F, Smith CG, Heider K, Su J, van der Pol Y, Thompson M, Morris J, Wan JCM, Chandrananda D, Hadfield J, Grzelak M, Hudecova I, Couturier DL, Cooper W, Zhao H, ... ... Rosenfeld N, et al. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients. Embo Molecular Medicine. e12881. PMID 34291583 DOI: 10.15252/emmm.202012881 |
0.272 |
|
| 2021 |
Hudecova I, Smith CG, Hänsel-Hertsch R, Chilamakuri C, Morris JA, Vijayaraghavan A, Heider K, Chandrananda D, Cooper WN, Gale D, Garcia-Corbacho J, Pacey SC, Baird R, Rosenfeld N, Mouliere F. Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA. Genome Research. PMID 34930798 DOI: 10.1101/gr.275691.121 |
0.272 |
|
| 2019 |
Pritchett MA, Camidge DR, Patel M, Khatri J, Boniol S, Friedman EK, Khomani A, Dalia S, Baker-Neblett K, Plagnol V, Howarth KD, Jones GR, Rosenfeld N, Morris CD, Govindan R. Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer. Jco Precision Oncology. 3. PMID 32914040 DOI: 10.1200/PO.18.00299 |
0.271 |
|
| 2008 |
Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, et al. MicroRNAs accurately identify cancer tissue origin. Nature Biotechnology. 26: 462-9. PMID 18362881 DOI: 10.1038/Nbt1392 |
0.271 |
|
| 2022 |
Markus H, Chandrananda D, Moore E, Mouliere F, Morris J, Brenton JD, Smith CG, Rosenfeld N. Refined characterization of circulating tumor DNA through biological feature integration. Scientific Reports. 12: 1928. PMID 35121756 DOI: 10.1038/s41598-022-05606-z |
0.269 |
|
| 2008 |
Barshack I, Rosenwald S, Bronfeld M, Aviel-Ronen S, Meiri E, Zepeniuk M, Shabes N, Tabak S, Cohen D, Rosenfeld N. MicroRNA expression profile identifies origin of tumors in the liver Journal of Clinical Oncology. 26: 11026-11026. DOI: 10.1200/Jco.2008.26.15_Suppl.11026 |
0.264 |
|
| 2009 |
Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwick Yanai G, Elyakim E, Cholakh H, Gibori H, ... ... Rosenfeld N, et al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathology (Zurich, Switzerland). 19: 375-83. PMID 18624795 DOI: 10.1111/J.1750-3639.2008.00184.X |
0.262 |
|
| 2019 |
Succony L, Rosenfeld N, Rintoul RC. Multimodality Approaches to Screening for Lung Cancer. Clinical Oncology. 31: 702-705. PMID 31444024 DOI: 10.1016/J.Clon.2019.07.024 |
0.258 |
|
| 2007 |
Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell. 26: 731-43. PMID 17540598 DOI: 10.1016/J.Molcel.2007.05.017 |
0.254 |
|
| 2023 |
Santonja A, Cooper WN, Eldridge MD, Edwards PAW, Morris JA, Edwards AR, Zhao H, Heider K, Couturier DL, Vijayaraghavan A, Mennea P, Ditter EJ, Smith CG, Boursnell C, Manzano García R, ... ... Rosenfeld N, et al. Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer. Embo Molecular Medicine. e16505. PMID 37161793 DOI: 10.15252/emmm.202216505 |
0.247 |
|
| 2017 |
Forshew T, Lawson A, Smalley S, Plagnol V, Calaway J, Blais S, Howarth K, Jones G, Pugh M, Madi M, Durham B, Musgrave-Brown E, Woodhouse S, Rosenfeld N, Gale D, et al. P2.03b-093 Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories Journal of Thoracic Oncology. 12: S992-S993. DOI: 10.1016/J.Jtho.2016.11.1375 |
0.247 |
|
| 2021 |
Nteliopoulos G, Page K, Hills A, Howarth K, Emmett W, Green E, Martinson LJ, Fernadez-Garcia D, Hastings R, Guttery DS, Kenny L, Stebbing J, Cleator S, Rehman F, Gleason KLT, ... ... Rosenfeld N, et al. Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients. Breast Cancer Research and Treatment. PMID 34097174 DOI: 10.1007/s10549-021-06220-9 |
0.244 |
|
| 2013 |
Voon PJ, Tsui DW, Rosenfeld N, Chin TM. EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib--Letter. Molecular Cancer Therapeutics. 12: 2614-5. PMID 23969006 DOI: 10.1158/1535-7163.Mct-13-0192 |
0.242 |
|
| 2015 |
Schwarz RF, Ng CKY, Cooke SL, Newman S, Temple J, Piskorz AM, Gale D, Sayal K, Murtaza M, Baldwin PJ, Rosenfeld N, Earl HM, Sala E, Jimenez-Linan M, Parkinson CA, et al. Clonal expansion index stratifies patients into prognostic subgroups. Plos Medicine. DOI: 10.1371/Journal.Pmed.1001789.G005 |
0.241 |
|
| 2020 |
Marsico G, Sharma G, Perry M, Hackinger S, Forshew T, Howarth K, Platt J, Rosenfeld N, Osborne R. Abstract 3097: Analytical development of the RaDaRTMassay, a highly sensitive and specific assay for the monitoring of minimal residual disease Clinical Trials. DOI: 10.1158/1538-7445.Am2020-3097 |
0.238 |
|
| 2008 |
Benjamin H, Lebanony D, Cohen L, Elyakim E, Rosenfeld N, Chajut A, Cohen D. Differential diagnosis of mesothelioma using a microRNA assay Journal of Clinical Oncology. 26: 22000-22000. DOI: 10.1200/Jco.2008.26.15_Suppl.22000 |
0.233 |
|
| 2022 |
Wan JCM, Mughal TI, Razavi P, Dawson SJ, Moss EL, Govindan R, Tan IB, Yap YS, Robinson WA, Morris CD, Besse B, Bardelli A, Tie J, Kopetz S, Rosenfeld N. Liquid biopsies for residual disease and recurrence. Med (New York, N.Y.). 2: 1292-1313. PMID 35590147 DOI: 10.1016/j.medj.2021.11.001 |
0.229 |
|
| 2017 |
Mock A, Murphy S, Morris J, Marass F, Rosenfeld N, Massie C. CVE: an R package for interactive variant prioritisation in precision oncology. Bmc Medical Genomics. 10: 37. PMID 28545463 DOI: 10.1186/S12920-017-0261-6 |
0.227 |
|
| 2016 |
Köbel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F, Rosenfeld N, Mes Masson AM, Brenton JD. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. The Journal of Pathology. Clinical Research. 2: 247-258. PMID 27840695 DOI: 10.1002/cjp2.53 |
0.211 |
|
| 2020 |
Gill AB, Rundo L, Wan JCM, Lau D, Zawaideh JP, Woitek R, Zaccagna F, Beer L, Gale D, Sala E, Couturier DL, Corrie PG, Rosenfeld N, Gallagher FA. Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma. Cancers. 12. PMID 33255267 DOI: 10.3390/cancers12123493 |
0.208 |
|
| 2013 |
Dawson SJ, Rosenfeld N, Caldas C. Circulating tumor DNA to monitor metastatic breast cancer. The New England Journal of Medicine. 369: 93-4. PMID 23822788 DOI: 10.1056/NEJMc1306040 |
0.208 |
|
| 2013 |
Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Rozenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, et al. Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 23: 634-46. PMID 23680148 DOI: 10.1016/J.Ccr.2013.03.022 |
0.205 |
|
| 2024 |
Pope B, Park G, Lau E, Belic J, Lach R, George A, McCoy P, Nguyen A, Grima C, Campbell B, Jung CH, Ditter EJ, Zhao H, Wedge DC, Brewer DS, ... ... Rosenfeld N, et al. Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer. European Urology. PMID 38378299 DOI: 10.1016/j.eururo.2024.01.002 |
0.185 |
|
| 2016 |
Massie C, Rosenfeld N. Proffered Paper: Enhancing sensitivity for analysis of circulating tumour DNA European Journal of Cancer. 61: S4. DOI: 10.1016/S0959-8049(16)61008-0 |
0.177 |
|
| 2022 |
Fitzgerald RC, Antoniou AC, Fruk L, Rosenfeld N. The future of early cancer detection. Nature Medicine. 28: 666-677. PMID 35440720 DOI: 10.1038/s41591-022-01746-x |
0.172 |
|
| 2009 |
Mansukhani MM, Rosenfeld N. Reply to G. Rossi et al Journal of Clinical Oncology. 27. DOI: 10.1200/Jco.2009.24.0903 |
0.17 |
|
| 2022 |
Sauer CM, Heider K, Belic J, Boyle SE, Hall JA, Couturier DL, An A, Vijayaraghavan A, Reinius MA, Hosking K, Vias M, Rosenfeld N, Brenton JD. Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models. Embo Molecular Medicine. e15729. PMID 35694774 DOI: 10.15252/emmm.202215729 |
0.164 |
|
| 2020 |
Biasci D, Smoragiewicz M, Connell CM, Wang Z, Gao Y, Thaventhiran JED, Basu B, Magiera L, Johnson TI, Bax L, Gopinathan A, Isherwood C, Gallagher FA, Pawula M, Hudecova I, ... ... Rosenfeld N, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proceedings of the National Academy of Sciences of the United States of America. PMID 33127761 DOI: 10.1073/pnas.2013644117 |
0.153 |
|
| 2023 |
van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, ... ... Rosenfeld N, et al. High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nature Medicine. PMID 36732628 DOI: 10.1038/s41591-022-02199-y |
0.148 |
|
| 2023 |
Crispin-Ortuzar M, Woitek R, Reinius MAV, Moore E, Beer L, Bura V, Rundo L, McCague C, Ursprung S, Escudero Sanchez L, Martin-Gonzalez P, Mouliere F, Chandrananda D, Morris J, Goranova T, ... ... Rosenfeld N, et al. Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer. Nature Communications. 14: 6756. PMID 37875466 DOI: 10.1038/s41467-023-41820-7 |
0.14 |
|
| 2023 |
van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, ... ... Rosenfeld N, et al. Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nature Medicine. PMID 37460757 DOI: 10.1038/s41591-023-02500-7 |
0.087 |
|
| Hide low-probability matches. |